New anticoagulant drug class in development

Data were recently presented on a new drug class, precision oral anticoagulants (PROACs) at the recent International Stroke Conference 2019, organised by the American Heart Association and held in Honolulu, Hawaii, USA.

Source link

Related posts

Reply: Free Androgen Index as a Biomarker of Increased Cardiovascular Risk in Postmenopausal Women


Incidence, 30-day readmission rates and predictors of readmission after new onset atrial fibrillation who underwent transcatheter aortic valve replacement.


Aortic elongation part I: the normal aortic ageing process


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy